Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Myeloid Leukemia

Clinical trial NCT04867928 · UNKNOWN

Trial details

NCT number: NCT04867928
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Myeloid Leukemia, in Relapse NPM1 Mutation

Start date: 2022-03-01
Primary completion: 2025-01-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.